mRNA-2416

N/A

Report date: 2026/05/12 09:10:26

NME

Base Information

Drug NamemRNA-2416

Drug Alias NamemRNA-2416OX40L mRNA - Moderna Therpeutics

ClassificationCell and gene therapy > Gene therapy > mRNASmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide

Mechanisms of ActionImmunostimulantsTumor necrosis factor receptor superfamily member 4 modulatorsTumor necrosis factor ligand superfamily member 4 inhibitors

TargetsTumor necrosis factor ligand superfamily member 4Tumor necrosis factor receptor superfamily member 4

Therapy Area/IndicationsSolid tumoursOvarian NeoplasmsLymphoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesModerna Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesModerna Inc

Active IndicationsN/A

Inactive IndicationsSolid tumoursOvarian NeoplasmsLymphoma

Other Information

ATC CodeN/A